NCT01172145View on ClinicalTrials.gov

Treatment of Apathy in Alzheimer's Disease With Modafinil

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

September 30, 2007

Conditions
ApathyAlzheimer's Disease
Interventions
DRUG

Modafinil

100 mg in the morning for the first week and 200 mg in the morning for the remaining seven weeks

DRUG

Placebo

100 mg in the morning for the first week and 200 mg in the morning for the remaining seven weeks

Trial Locations (1)

02906

Butler Hospital, Providence

Sponsors

Lead Sponsor

Brown University

Collaborators (1)

Cephalon
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

Cephalon

INDUSTRY

lead

Brown University

OTHER